Clinical trial Recruiting at 1 site Observational Ages 18 and up

Identifying genetic markers for Brugada Syndrome diagnosis

Official title: Unveiling the Genetic Landscape of Brugada Syndrome: Novel Biomarker Discovery for Precise Diagnosis

Run by IRCCS Policlinico S. Donato · NCT06647927 · Data updated 2026-11-12

This study is testing if new genetic tools can help doctors better diagnose Brugada Syndrome and create more personalized treatment plans for patients.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment350 (estimated)
SponsorIRCCS Policlinico S. Donato
Academic / other
Locations1 site (San Donato Milanese, Milan)
StatusRecruiting
StartedDecember 2, 2024
Main results expectedMay 2026
Study endsSeptember 2026
Registry record updatedMay 14, 2025
Trial IDNCT06647927 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old who have been diagnosed with Brugada Syndrome.

Probably not a fit

Patients who do not have Brugada Syndrome or are under 18 years old will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research focuses on improving the diagnosis of Brugada Syndrome (BrS) through advanced genetic sequencing techniques. By developing a genetic signature and identifying specific biomolecular profiles, the study aims to enhance understanding of the syndrome's molecular mechanisms. The approach includes a multi-omic strategy that integrates whole-exome sequencing and machine learning to uncover altered pathways related to BrS. The ultimate goal is to facilitate personalized treatment plans and refined risk assessment for patients affected by BrS.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and efficient diagnoses of Brugada Syndrome, enabling better-targeted therapies.

How similar studies have gone: Other studies have shown promise in using genetic sequencing for diagnosing cardiac conditions, suggesting potential success for this approach in Brugada Syndrome.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 years
* Patients affected by Brugada Syndrome
* Patients who signs the Informed Consent

Exclusion Criteria:

* None

Where it's running

  • Irccs Policlinico San Donato
    San Donato Milanese, Milan, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.